Janel Corp
janelcorp.comJanel Corp (OTC: JANL) is a diversified holding company that operates across three segments: Logistics, Life Sciences, and Manufacturing. The Logistics segment provides non-asset-based cargo transportation management services including air, ocean, and land freight forwarding, customs brokerage, warehousing and distribution, and trucking under brands including Airschott and Interlog USA. The Life Sciences segment manufactures and distributes antibodies and research and diagnostic reagents, and provides custom services to academic, non-profit, and commercial customers, with subsidiaries including ViraQuest Inc. (acquired February 1, 2024) and Biosensis Pty Ltd (80% acquired June 4, 2025), an Australia-based biotech focused on drug development for brain diseases. The Manufacturing segment operates through wholly-owned Indco, Inc., which manufactures and distributes mixing equipment for small- to mid-sized businesses and larger production customers. The company grows primarily through acquisitions across all three segments.
Products & Services
Logistics: air freight forwarding, ocean freight forwarding, land freight forwarding, customs brokerage, warehousing and distribution, trucking, accessorial services (fuel surcharges, hazardous cargo fees, cartage, bonding). Life Sciences: antibodies, research and diagnostic reagents, custom laboratory services, drug development research (Biosensis). Manufacturing: mixing equipment and apparatuses for industrial applications (Indco).
Revenue Model
Logistics revenue is transactional, earned on freight forwarding, customs brokerage, warehousing, and trucking services, supplemented by accessorial revenues such as fuel surcharges, wait time fees, hazardous cargo fees, and handling charges. Life Sciences revenue comes from product sales of antibodies and reagents plus fees for custom services. Manufacturing revenue is transactional, generated by selling mixing equipment to industrial customers.
Customers & Markets
Logistics customers are businesses requiring international and domestic cargo movement. Life Sciences customers include academic institutions, non-profit organizations, and commercial customers in research and diagnostics. Manufacturing customers are small- to mid-sized businesses and larger enterprises with repetitive production order needs across various industries.
Geographic Exposure
Primarily United States-based operations across all three segments. Life Sciences expanded internationally with the acquisition of Biosensis Pty Ltd in Australia (completed June 4, 2025). Logistics operations include international freight forwarding covering air and ocean routes.
Loading...
